Recurrent High Grade Uterine Cancer
1 clinical trials · Condition
◉ Watch Recurrent High Grade Uterine Cancer
| Record | Firm | Date |
|---|---|---|
| AVB-500 (Batiraxcept) in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer (NCT05826015) | Washington University School of Medicine | 2024-10-31 |
Track Recurrent High Grade Uterine Cancer automatically
Every clearance here is in the API, with alerts when new ones post.